Philip Morris International Renews Call to Policymakers and Civil Society to Help End Smoking
19 September 2022 - 2:00PM
Business Wire
As UNGA convenes, PMI continues on its path of
industry disruption and calls on all stakeholders to do their part
in achieving a world without cigarettes
Philip Morris International Inc. (PMI) (NYSE: PM) is calling on
policymakers, regulators, public health advocates, tobacco
companies, and activists to unite behind bringing about the end of
cigarette smoking.
As the United Nations General Assembly (UNGA) convenes to
discuss global challenges, the company is releasing a white paper,
Rethinking Disruption: Innovating for Better in an Era of Division,
which previews select findings from a new international survey
highlighting the broad societal support for disruptive innovations
to improve public health and address other critical issues. The
white paper explores how the world’s most significant
challenges—including smoking—can be solved through pragmatic
solutions and decisive, concerted action.
The survey respondents (17,207 adults aged 21 and older in 14
countries) believe that the development and adoption of new
technologies, innovations, and capabilities can enable significant
progress against a range of issues over the next 10 to 20 years,
including:
- Encouraging healthier eating habits (78 percent)
- Ensuring quality and affordable healthcare for all (72
percent)
- Reducing smoking rates (65 percent)
- Eliminating hunger and malnourishment (62 percent)
“We believe that there exists a real opportunity for activists,
public health leaders, and policymakers to significantly improve
public health by helping millions of adults who would otherwise
continue to smoke switch to better alternatives,” said Jacek
Olczak, CEO, PMI. “For more than a decade, PMI has been
transforming for good, directing our resources and energy to
provide better options to adult smokers and deliver a smoke-free
future as quickly as possible. Though the best choice is never to
start smoking or to quit if you do, we know that, realistically,
many smokers will not quit—and, frankly, those adults deserve
better.”
Senior PMI executives, including Jacek Olczak, will address
international forums during the week of September 19, talking about
the pressing need for collaboration on solutions that are real,
practical, and grounded in science to achieve meaningful progress
in the tobacco sector and beyond.
Events include:
- September 20: CEO Jacek Olczak will address the 2022
Concordia Annual Summit on the topic of “Driving Change in the Age
of Disruption.”
- September 20: SVP, External Affairs Grégoire Verdeaux
will join the Diplomatic Courier for a panel discussion on “The
Global Goals in Action 2022: Reduced Inequalities.”
- September 21: Deepak Mishra, President, Americas Region,
will join Recount Media for a breakfast panel titled, “From
Disruption to Progress—Innovating for Better in the Age of
Division.”
- September 22: CEO Jacek Olczak will be a panelist at a
custom event with the Wall Street Journal on “Disruption 2.0: Build
Up Not Break Down.”
- September 22: CEO Jacek Olczak will participate in the
Leaders on Purpose CEO Summit, addressing the “Transition on
Purpose: Leading Systemic Business Model Transformation in Times of
Disruption.”
Today, better alternatives to continued smoking exist and can
bring about radical, positive change for public health—creating a
future in which cigarettes are obsolete. Real-world evidence shows
that providing adult smokers access to these innovative,
scientifically substantiated smoke-free products—while protecting
youth and nonsmokers—is an effective tool in reducing smoking
rates. By embracing this opportunity for meaningful tobacco harm
reduction, governments, public health authorities, and civil
society can harness the power of science and innovation to achieve
disruptive change that benefits adults who smoke and the public
health.
“Innovation is a crucial piece of the solution of eliminating
cigarettes, but it’s not the only piece,” said Grégoire Verdeaux,
Senior Vice President, External Affairs, PMI. “Once scientific and
technological advances have been made, regulations need to keep up.
Policies should reflect that certain tobacco and nicotine products
are less harmful and ensure that adult smokers who do not quit can
access and afford these better alternatives to cigarettes. This is
especially true in developing countries, where most smokers
are.”
To learn more about how PMI is delivering a smoke-free future
faster, visit PMI.com/rethinkdisruption.
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products,
including heat-not-burn, vapor, and oral nicotine products, which
are sold in markets outside the U.S. Since 2008, PMI has invested
more than USD 9 billion to develop, scientifically substantiate,
and commercialize innovative smoke-free products for adults who
would otherwise continue to smoke, with the goal of completely
ending the sale of cigarettes. This includes the building of
world-class scientific assessment capabilities, notably in the
areas of pre-clinical systems toxicology, clinical and behavioral
research, as well as post-market studies. The U.S. Food and Drug
Administration (FDA) has authorized the marketing of versions of
PMI’s IQOS Platform 1 devices and consumables as Modified Risk
Tobacco Products (MRTPs), finding that exposure modification orders
for these products are appropriate to promote the public health. As
of June 30, 2022, excluding Russia and Ukraine, PMI’s smoke-free
products were available for sale in 70 markets, and PMI estimates
that approximately 13.2 million adults around the world had already
switched to IQOS and stopped smoking. With a strong foundation and
significant expertise in life sciences, in February 2021 PMI
announced its ambition to expand into wellness and healthcare areas
and deliver innovative products and solutions that aim to address
unmet consumer and patient needs. For more information, please
visit www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220919005428/en/
David Fraser Philip Morris International David.Fraser@pmi.com
+41 (0)58 242 4500
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Apr 2023 bis Apr 2024